Skip to content

Imunon, Inc.

IMNN

CIK 0000749647 · Pharmaceutical Preparations · Nasdaq

  • CELSION CORP (until 2022-09-19)
  • Celsion CORP (until 2022-09-19)
  • CHEUNG LABORATORIES INC (until 1998-02-17)
Revenue (TTM)
$500K
0.0% YoY Q1 May 2026
Net Income (TTM)
−$14.52M
+22.2% YoY Q1 May 2026
EPS Diluted (TTM)
−$7.30
+59.7% YoY Q1 May 2026
Gross Margin
Q1 May 2026
Operating Margin
-2,939.1%
Q1 May 2026
Net Margin
-2,904.2%
Q1 May 2026
Free Cash Flow (TTM)
−$17.07M
Q1 May 2026
Cash
$4.79M
Q1 May 2026
Total Debt
$6.08M
Q1 May 2026
Shares Outstanding
4.2M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings